Tu1883 Activation of the Nuclear Receptor FXR by Oral Chenodeoxycholic Acid in Patients With Crohn's Colitis: Potential Therapeutic Consequences for Inflammatory Bowel Disease

Authors :: Fiona D.M. van Schaik
Saskia W.C. van Mil
Bas Oldenburg
Frank G. Schaap
Raffaella Maria Gadaleta
Peter D. Siersema
Karel J. van Erpecum
Source :: Gastroenterology. 142:S-869
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Crohn's colitis
Gastroenterology
medicine.disease
Inflammatory bowel disease
chemistry.chemical_compound
Endocrinology
Nuclear receptor
chemistry
Internal medicine
Chenodeoxycholic acid
medicine
In patient
business

Tools